English
What is EFSA?
How to preserve the skin microbiota?
The skin microbiota plays a vital role in maintaining the skin's integrity and functionality. It contributes to the proper regulation of organisms and organs, allowing the skin to perform its essential functions, including acting as a barrier. See our latest article "Why preservce the skin microbiota ?"
GenoScreen bioinformatics training courses 2024
As a training organization, GenoScreen is offering bioinformatics training courses for professionals in 2024. Whether you are a novice or an expert, our training courses will give you the skills you need to master the analysis of NGS data and gain autonomy.
Why preserve the skin microbiota?
The skin serves as the first line of interaction with the external environment and as a defence mechanism against the physical, chemical, or biological stresses and challenges it encounters. The skin microbiota plays a key role in these interactions and defence functions. Formerly known as "skin flora", it colonises every square centimetre of the skin. Its role is fundamental to both skin health and the overall well-being of the body. What are the factors that influence its composition, and what disrupts its functions?
Skin microbiome's influence on skin health
The cutaneous microbiota has become a subject of interest for the nutri-cosmetics, dermo-cosmetics and beauty industries. New products have been launched that claim to respect the skin's microbiota, as well as skincare products containing a new category of active ingredients - pre-, pro- and post-biotics - designed to protect, rebalance or maintain its equilibrium. These innovations have been made possible by significant scientific and technological advances in the study of microbiota.
European Commission Proposal for a Directive on Soil Monitoring and Resilience
The European objective for 2050 is to achieve a healthy and more resilient soil. To support this objective, on Friday 7th of July, the European Commission published a Proposal for a Directive on Soil Monitoring and Resilience (Soil Monitoring Law) [1].
Exciting news in leprosy detection and surveillance. Think positive!
Although considered an extinct calamity, leprosy is an infectious disease still present in more than hundred countries.
Subcategories
GenoScreen
Partners
At GenoScreen, our genomics expertise is built on collaboration with a dense network of scientific, industrial and institutional partners. These partnerships strengthen our ability to innovate, co-develop new technologies and advance research in molecular microbiology.
A network of strategic partners
We actively collaborate with:
Research institutes, universities and hospitals
Competitive clusters specialized in biotechnology and healthcare
Public funding bodies
A co-development strategy
Our research projects are carried out with recognized partners in France and abroad. Together, we can :
- Co-develop innovative genomics and bioinformatics solutions
- Reply to national and international applications for projects (Horizon Europe, ANR, etc.)
- Test and validate our technologies in a variety of environments
- Launch the implementation of concrete solutions for health, agriculture and the environment
Why collaborate with GenoScreen?
- Access to an innovative sequencing technology platform
- Access to recognized expertise in bioinformatics analysis and biomarkers
- Benefit from our ability to manage collaborative R&D projects
- Strive for health, agriculture and environment
Join our network of partners
Do you represent a company, laboratory or public body? Contact us to discuss a collaboration or partnership.
Frequently asked questions
What kind of partners work with GenoScreen?
GenoScreen works with academic laboratories, biotech companies and clusters.
What are the benefits of these partnerships?
They help us co-develop technologies, co-finance projects and accelerate innovation.
How can I propose a partnership?
You can contact us via our contact form to discuss your project and identify a potential collaboration.
Collaborative research - At the heart of international innovation in genomics
GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.
Our projects are designed to:
- Improve the diagnosis and management of acute/chronic diseases on humans and animals,
- Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.
The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.